GlassScriptPhysician profile
Jeffrey S Aronoff
NPI 1699869883
$4,047.19
in general payments reported to CMS, 2019-2025
36 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $346 · 2020: $1,084 · 2021: $874 · 2022: $382 · 2023: $723 · 2024: $296 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,360.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Palette Life Sciences, INC. | $697.96 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $495.58 | 2019-2025 | Xifaxan, Trulance |
| Abbvie INC. | $381.32 | 2019-2025 | Linzess |
| Medical Device Business Services, INC. | $305.00 | 2021 | |
| Qol Medical, LLC | $300.54 | 2019-2024 | Sucraid, Sucraid |
| Baxter Healthcare | $242.83 | 2023 | Tisseel |
| Braintree Laboratories, INC. | $238.70 | 2021-2024 | Suflave, Sutab |
| Axonics, INC. | $186.25 | 2023 | Bulkamid |
| Medtronic USA, INC. | $117.82 | 2019-2020 | |
| Medtronic, INC. | $117.24 | 2023-2025 | Interstim |
| Janssen Biotech, INC. | $113.05 | 2020-2025 | Stelara, Tremfya |
| Ardelyx, INC. | $73.37 | 2025 | Ibsrela |
| Takeda Pharmaceuticals U.S.A., INC. | $61.59 | 2021-2023 | Gattex |
| Regeneron Healthcare Solutions, INC. | $56.89 | 2023-2025 | Dupixent |
| Celltrion USA INC. | $56.49 | 2024-2025 | Vegzelma |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $56.40 | 2022 | |
| Redhill Biopharma INC. | $50.57 | 2020-2022 | |
| Novum Pharma, LLC | $50.24 | 2019 | |
| Ironwood Pharmaceuticals, INC | $41.28 | 2021-2022 | |
| Ethicon US, LLC | $39.59 | 2021 | |
| Phathom Pharmaceuticals, INC. | $38.49 | 2024 | Voquezna |
| Intercept Pharmaceuticals, INC. | $30.22 | 2021 | |
| Integra Lifesciences Corporation | $28.85 | 2022 | |
| Acell, INC. | $28.19 | 2019 | |
| Myriad Genetic Laboratories, INC. | $26.11 | 2021 | |
| Glaxosmithkline, LLC. | $25.39 | 2019-2020 | |
| Shire North American Group INC | $24.74 | 2019 | |
| Evoke Pharma, INC. | $22.87 | 2023 | Gimoti |
| Vbi Vaccine (Delaware) INC. | $22.71 | 2023 | Prehevbrio |
| Genentech USA, INC. | $18.53 | 2019 | |
| Exact Sciences Corporation | $18.29 | 2023 | Cologuard Collection Kit |
| Trevena, INC. | $17.60 | 2021 | |
| Olympus America INC. | $17.19 | 2025 | Olympus |
| Ferring Pharmaceuticals INC. | $15.95 | 2022 | |
| Romark Laboratories, Lc | $14.75 | 2019 | |
| Lilly USA, LLC | $14.60 | 2025 | Zepbound, Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Aronoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.